RDNTRadNet, Inc.

$5B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$461M+14.7% YoY

Gross Profit

$69M15.0% margin

Operating Income

$34M7.4% margin

Net Income

$3M0.7% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$57M

Free Cash Flow

$16M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$2.2B

Stockholders' Equity

$895M

Cash & Equivalents

$749M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$461M	$402M	+14.7%
Gross Profit	$69M	$60M	+14.9%
Operating Income	$34M	$43M	-21.6%
Net Income	$3M	$18M	-81.7%

Revenue Segments

Service

$461M51%

Commercial Insurance1

$255M28%

Medicare1

$103M11%

Capitation Arrangements

$34M4%

Medicaid1

$11M1%

Health Care, Patient Service Other

$11M1%

Health Care, Other

$10M1%

Workers' Compensation/Personal Injury1

$10M1%

Health Care, Management Service

$6M1%

RDNT Q3 2024 Earnings — RadNet, Inc. Revenue & Financial Results | Market Cap Arena